La utilidad de marcadores no-invasivos para predecir las hepatopatias cronicas .5
73. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 1997; 92: 1302–4.
74. Hui AY, Chan HL, Wong VW. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am. J. Gastroenterol. 2005; 100: 616–23.
75. Schiavon LL, Narciso-Schiavon JL, Carvalho Filho RJ. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection. J. Viral Hepat. 2008; 15: 666–74.
76. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am. J. Gastroenterol. 2004; 99: 1160–74.
77. Giannini EG, Zaman A, Ceppa P, Mastracci L, Risso D, Testa R. A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice. J. Clin. Gastroenterol. 2006; 40: 521–7.
78. Wright TL. Introduction to chronic hepatitis B infection. Am. J. Gastroenterol 2006; 101 (Suppl. 1): S1–6.
79. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825–32.
80. Rozario R, Ramakrishna B. Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. J. Hepatol. 2003; 38: 223–9.
81. Bartos V, Krkoska D, Slavik P, Lauko L, Adamkov M. Histological status of the liver in relation to serum aminotransferase levels in patients with chronic hepatitis C. Bratisl. Lek. Listy 2007; 108: 522–5.
82. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069–75.
83. Cioni G, Tincani E, D'Alimonte P. Relevance of reduced portal flow velocity, low platelet count and enlarged spleen diameter in the non-invasive diagnosis of compensated liver cirrhosis. Eur. J. Med. 1993; 2: 408–10.